Vendeur : HPB-Movies, Dallas, TX, Etats-Unis
EUR 29,75
Quantité disponible : 1 disponible(s)
Ajouter au panierhardcover. Etat : Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Vendeur : HPB-Red, Dallas, TX, Etats-Unis
EUR 29,75
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
EUR 16,27
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
EUR 16,98
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : New.
Langue: anglais
Edité par Berlin/ Heidelberg, Springer Berlin., 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : Universitätsbuchhandlung Herta Hold GmbH, Berlin, Allemagne
EUR 18
Quantité disponible : 1 disponible(s)
Ajouter au panier2010. 16 x 24 cm. XIV, 231 S. XIV, 231 p. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Recent Results in Cancer Research). Sprache: Englisch.
Vendeur : Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Royaume-Uni
EUR 28,41
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New.
EUR 16,86
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : New.
Vendeur : SpringBooks, Berlin, Allemagne
EUR 19,95
Quantité disponible : 1 disponible(s)
Ajouter au panierSoftcover. Etat : As New. Like new. Immediately dispatched from Germany.
EUR 19,65
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Royaume-Uni
EUR 42,26
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New.
Vendeur : Antiquariat Bookfarm, Löbnitz, Allemagne
EUR 8,25
Quantité disponible : 1 disponible(s)
Ajouter au panier808 Seiten Ehemaliges Bibliotheksexemplar mit Stempel und Rückensignatur. Leichte bis Moderate Lager und Gebrauchsspuren. Guter Zustand. 9783836216227 Sprache: Deutsch Gewicht in Gramm: 1461.
Vendeur : Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Royaume-Uni
EUR 75,82
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : As New.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 128,06
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 144,66
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 168,62
Quantité disponible : 2 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. 2010 edition. 248 pages. 9.20x6.10x0.56 inches. In Stock.
Vendeur : preigu, Osnabrück, Allemagne
EUR 104,15
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Angiogenesis Inhibition | Rüdiger Liersch (u. a.) | Taschenbuch | xiv | Englisch | 2012 | Springer | EAN 9783642261435 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 120,54
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 201,53
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 113,64
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 242,89
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 248.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 238,44
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Brand New. 1st edition. 231 pages. 9.00x6.00x0.50 inches. In Stock.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 7,69
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Seiten: 952 | Produktart: Bücher | Keine Beschreibung verfügbar.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 26,90
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Seiten: 866 | Produktart: Bücher | Keine Beschreibung verfügbar.
Vendeur : BUCHSERVICE / ANTIQUARIAT Lars Lutzer, Wahlstedt, Allemagne
EUR 189,90
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : gut. Reporting mit SAP BW und SAP BusinessObjects: Alle Tools in einem Buch - BEx und BO (SAP PRESS) In deutscher Sprache. pages.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 94,25
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 126,26
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Langue: anglais
Edité par Springer Berlin Heidelberg Mai 2012, 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 117,69
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. 248 pp. Englisch.
Langue: anglais
Edité par Springer Berlin Heidelberg, 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : moluna, Greven, Allemagne
EUR 98,54
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A general overview of the latest developments in angiogenesis inhibition in cancerConsiders all aspects from the bench to the bedside, with detailed attention both to basic research and to its translation into clinical practicePresents the .
Langue: anglais
Edité par Springer, J.B. Metzler Mai 2012, 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 117,69
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 248 pp. Englisch.
Langue: anglais
Edité par Springer Berlin Heidelberg, 2009
ISBN 10 : 354078280X ISBN 13 : 9783540782803
Vendeur : moluna, Greven, Allemagne
EUR 132,75
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A general overview of the latest developments in angiogenesis inhibition in cancerConsiders all aspects from the bench to the bedside, with detailed attention both to basic research and to its translation into clinical practicePresents the .